Analyst Recommendations
14.44 -1.00(-6.48%)06/28/2024
Verona Pharma Plc (VRNA)
Verona Pharma Plc (VRNA)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 7 |
Outperform | 1 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades